BUY Honasa Consumer — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))25 Jun 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·9 Jul · today
Honasa Consumer Ltd has acquired a majority stake (58%) in Fluence Pharma, a science-backed nutraceuticals company. This strategic move marks Honasa's entry into the high-growth nutraceuticals market,
BSE · Company Update·23 Jun · 2w ago
Honasa Consumer Limited is entering the nutraceuticals market by acquiring a majority stake in Fluence Pharma.
NSE · Press Release·23 Jun · 2w ago
Honasa Consumer Ltd received approval for the acquisition of Fluence Pharma Private Limited and the incorporation of a wholly owned subsidiary.
BSE · Company Update·23 Jun · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Honasa Consumer
- BUY — HSBC Securities21 Oct 2026 · ~1 year · target ₹554 · Active
- BUY — Equirus Securities29 Sept 2026 · ~1 year · target ₹595 · Active
- BUY — Arun Kumar Mantri23 Sept 2026 · ~2 weeks · target ₹504 · SL hit
- BUY — IDBI Capital23 Sept 2026 · ~2 weeks · target ₹508 · SL hit
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~2 weeks · target ₹495 · SL hit
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

